Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
- COVID-19
Feb 4, 2021
Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine
- COVID-19
Feb 3, 2021
Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada
- COVID-19
Feb 2, 2021
Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science
- COVID-19
Feb 1, 2021
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
- COVID-19
Jan 28, 2021
Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management
- Corporate and Finance
Jan 22, 2021
Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine
- COVID-19
Jan 22, 2021
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
- Corporate and Finance
Jan 15, 2021
Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine
- COVID-19
Jan 7, 2021
Novavax to Participate in Upcoming Conferences
- Corporate and Finance
Jan 6, 2021

Show per page